Compare

MetaVia Inc. vs Mira Pharmaceuticals, Inc. vs Decoy Therapeutics Inc. vs Lantern Pharma Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	MetaVia Inc. MTVA	Mira Pharmaceuticals, Inc. MIRA	Decoy Therapeutics Inc. DCOY	Lantern Pharma Inc. LTRN
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$12.97M	-$10.44M	-$12.52M	-$17.12M
EPS (Diluted)	-$7.35	-$1.35	-$129.10	-$1.57
Operating cash flow	-$15.70M	-$4.66M	-$4.83M	-$15.68M
Free cash flow	-$15.70M	n/a	-$5.40M	-$15.68M
Cash & equivalents	$10.28M	$6.35M	$10.71M	$4.42M
Total assets	$11.12M	$11.09M	$11.06M	$11.04M
Total liabilities	$5.79M	$702.1K	$5.17M	$4.50M
Shareholders' equity	$5.33M	$10.39M	$5.89M	$6.53M
Return on year-end equity	-243.3%	-100.5%	-212.6%	-262.0%
Shares outstanding	2.31M	41.94M	n/a	11.25M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	MetaVia Inc.	Mira Pharmaceuticals, Inc.	Decoy Therapeutics Inc.	Lantern Pharma Inc.
Latest	n/a	n/a	$0 Ended 2022-12-31	n/a
1 year earlier	n/a	n/a	$1.84M Ended 2021-12-31	n/a
2 years earlier	n/a	n/a	$5.23M Ended 2020-12-31	n/a
3 years earlier	n/a	n/a	$3.47M Ended 2019-12-31	n/a
4 years earlier	n/a	n/a	$1.95M Ended 2018-12-31	n/a